NEW YORK LIFE INVESTMENTS ET - NYLI FTSE INTERN (HFXI)

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / NYLI FTSE INTERN
Number of holders
30
Total 13F shares, excl. options
11,194,885
Shares change
-236,601
Total reported value, excl. options
$267,555,000
Value change
-$5,597,018
Number of buys
14
Number of sells
-17
Price
$23.9

Significant Holders of NEW YORK LIFE INVESTMENTS ET - NYLI FTSE INTERN (HFXI) as of Q1 2021

34 filings reported holding HFXI - NEW YORK LIFE INVESTMENTS ET - NYLI FTSE INTERN as of Q1 2021.
NEW YORK LIFE INVESTMENTS ET - NYLI FTSE INTERN (HFXI) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 11,194,885 shares .
Largest 10 shareholders include NEW YORK LIFE INVESTMENT MANAGEMENT LLC (6,638,309 shares), UBS Group AG (1,167,581 shares), BANK OF AMERICA CORP /DE/ (862,944 shares), MORGAN STANLEY (852,166 shares), Raymond James Financial Services Advisors, Inc. (241,777 shares), COMMONWEALTH EQUITY SERVICES, LLC (196,780 shares), Ten Capital Wealth Advisors, LLC (183,003 shares), ROYAL BANK OF CANADA (164,387 shares), JANE STREET GROUP, LLC (146,756 shares), and Cambridge Investment Research Advisors, Inc. (136,103 shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.